Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Exec appointment
confidence 92%
filed 2026-05-20
Item 5.02
Scott Hortenstine is being designated as Sabre's principal accounting officer and Vice President and Controller, effective July 1, 2026. This is a material executive appointment to a key financial reporting role. While the disclosure also notes that Jami Kindle will continue as principal accounting officer through June 30, 2026, the principal disclosed action is Hortenstine's appointment to this critical position, making this an exec_appointment event.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-05-20
Item 1.01
Rehan Jaffer will be appointed to Six Flags' board of directors as a Class III director following the May 26, 2026 Annual Meeting, replacing departing director Arik Ruchim. The appointment is part of a Cooperation Agreement with H Partners, a significant long-term investor, and includes assignment to the Audit and Finance Committee, voting agreements, and standstill provisions affecting shareholder governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-20
Item 7.01
Andrew Clipsham was appointed as Interim Chief Financial Officer, effective upon Weinswig's departure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-20
Item 5.02
The filing discloses the appointment of Luke Wood to the board of directors following the board's approval to increase its size from twelve to thirteen members. While the section also mentions compensation under the Non-Employee Director Compensation Policy, the principal disclosed action is the appointment itself. The appointment of an experienced executive (former President of Beats by Dr. Dre and Apple VP) to the board is material to investors assessing governance and board composition.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-20
Item 5.02
The filing discloses the appointment of John Hazlett as Chief Financial Officer effective May 20, 2026, with detailed background, qualifications, and employment terms including base salary of $216,000 and performance incentives. While the section also mentions the departure of the prior CFO John Ferry, the principal disclosed action centers on the new appointment and its terms, making exec_appointment the most salient classification.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-05-20
Item 5.02
Michael Tarnok was appointed as a Class II director and Kevin Cameron (the CEO) was appointed as a Class III director; David Landskowsky resigned from the board. The board size increased from four to five members.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-05-20
Item 5.02
The filing discloses the appointment of David R. Wells as Chief Financial Officer and Board member effective May 18, 2026, approved by unanimous written consent. While the section also covers Tariq Rahim's resignation from the Board and transition from CFO, the principal disclosed action centers on the appointment of a new CFO and director, which is material to investors assessing the company's financial leadership and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-20
Item 5.02
The filing discloses the appointment of four new directors to the Board effective April 1, 2026: Elyssa Jacob Campbell, James C. Jones, Anthony Porter, and David Mauer. The disclosure provides detailed background on each appointee's professional experience and qualifications. This is a material governance event affecting board composition at a public company.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-20
Item 5.02
Ms. Elizabeth Magennis was appointed President of ConnectOne Bancorp at the annual reorganizational meeting, representing a promotion from Executive Vice President.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-20
The filing discloses the appointment of Gregg Hemphill as a director of Newton Golf Company, Inc., effective May 19, 2026, upon recommendation of the Nominating and Corporate Governance Committee. The Board also appointed him to serve on three committees (Audit, Compensation, and Nominating). While the disclosure includes compensation details (annual cash retainer of $30,000 and RSU grants), the principal disclosed action is the director appointment itself, making this an exec_appointment event. Director appointments are material to investors as they affect board composition and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-05-20
Item 5.02
The Board approved the appointment of Massimo Andolina as Group Chief Financial Officer, effective August 1, 2026, succeeding Emmanuel Babeau. This C-suite appointment is material to investors' assessment of the company's financial leadership and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-20
Item 5.02
The Board elected Adam Demuyakor to the Board effective June 1, 2026, and assigned him to three Board committees (Compensation, Risk Oversight, and Corporate Governance). This director appointment was disclosed via press release on May 20, 2026.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-05-20
Item 5.02
The filing centers on the Board's approval on May 17, 2026 of Robert Alex Walsh's appointment as Chief Financial Officer, effective July 13, 2026, succeeding Gaetano Franceschi. While the section also discloses Franceschi's departure and Walsh's compensation package (base salary $450,000, target incentive $450,000, RSU and PSU awards), the principal disclosed action is the appointment of a new CFO—a principal officer role material to investors. The compensation details are ancillary to the appointment itself.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-05-20
Item 5.02
The filing discloses both a director departure (Andres Small's resignation) and a director appointment (Rachael Wagner's appointment to the Board as a Class III director). While both events occurred on the same date, the appointment is the principal forward-looking action and receives substantive disclosure (independence determination, compensation terms, board composition post-appointment). The appointment of a new independent director to a 12-member board is material to investors assessing board composition and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-19
Item 5.02
Ali El-Haj was appointed as President, Chief Executive Officer, and Director of Rogers Corporation, effective immediately on May 19, 2026, transitioning from Interim President and CEO to permanent roles. The appointment includes compensation details including a base salary of $750,000, target incentive of 100% of base, and a $5,000,000 long-term equity grant.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-19
Item 5.02
The filing discloses the appointment of Carrie Anderson as Executive Vice President and Chief Financial Officer effective July 1, 2026, succeeding retiring Charles T. Lauber. While the section also mentions Lauber's retirement, the principal disclosed action centers on Anderson's appointment to a C-suite role, supported by detailed background, compensation terms ($1.5M RSU award), and benefit arrangements. This is a material executive appointment at a major industrial company.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-05-19
Item 5.02
The filing discloses the appointment of Thomas Dittrich as Executive Vice President and Chief Financial Officer effective September 1, 2026, along with detailed compensation arrangements including base salary (CHF 1,070,000), equity grants (CHF 4,500,000 target), sign-on RSU award (CHF 4,700,000), and retention bonus (CHF 5,800,000). While the section also mentions Peter Griffith's retirement, the substantive focus and length of disclosure centers on Dittrich's appointment and his comprehensive compensation package, making this primarily an exec_appointment event. The appointment of a CFO is material to investors as it affects the company's financial leadership and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-05-19
Item 5.02
The filing discloses both a director retirement (Gary Lehman) and a director appointment (Paul Fultz). While both events are mentioned, the appointment is the principal forward-looking action: Fultz was appointed to fill the vacancy and will serve on the Audit Committee. The explicit statement that Lehman's retirement "is not the result of any disagreement" suggests a routine transition, making the appointment the more salient event. Director changes are material to investors assessing board composition and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-19
Item 7.01
Scott R. Ward was elected as a director of Merit Medical Systems Inc., as announced via press release on Form 8-K.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-19
Item 8.01
The filing discloses the appointment of Keith D. Rose, M.D. as Chief Medical Officer, effective May 1, 2026. This is a material executive appointment to a senior leadership position. Dr. Rose's extensive background in medical affairs and clinical leadership across major pharmaceutical companies (Novocure, Ipsen, Jazz Pharmaceuticals, Indivior) demonstrates the significance of this hire to the Company's medical and clinical strategy.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-05-19
Item 5.02
The filing discloses multiple executive appointments on May 18, 2026: Dr. Miralles as President and Head of R&D (with $600,000 base salary, 45% bonus target, and substantial equity grants of 232,500 options and 77,500 RSUs), and Dr. Aslan as principal financial and accounting officer. While the section also includes departures (Dr. Miralles from the Board, Dr. Aslan from President, and Thad Huston as CFO), the principal disclosed actions center on the appointments of these executives to new roles with defined compensation packages, making exec_appointment the most salient classification.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-19
Item 5.02
The filing discloses the appointment of Jeff Newgard as President and Chief Executive Officer of GBank effective June 8, 2026, with detailed compensation terms including a $500,000 base salary, $100,000 sign-on bonus, equity grants of 20,000 restricted shares, and relocation assistance. While the section also mentions A. Lee Finley's resignation as a director, the principal and substantive disclosure centers on the executive appointment with comprehensive employment agreement details. This is a material executive appointment that would affect investor assessment of company leadership.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-19
Item 5.02
The filing discloses the appointment of Andrea Brimmer to the Board of Directors of Primo Brands Corporation, effective May 15, 2026, to fill a newly created vacancy. While the Board size increase is administrative, the principal disclosed action is the appointment of a director with significant executive experience (Chief Marketing and Public Relations Officer at Ally Financial Inc. since 2015) and board service at other public companies. This is a material corporate governance event affecting the composition of the Board.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-05-19
Item 5.02
EagleRock Land, LLC appointed six new directors on May 13, 2026: Richard H. Coats as chairman and Raj Kumar, Jeff S. Lott, James C. Nelson, Stephanie Reed, and Michael Wallace as board members, expanding the Board from one director to seven members in connection with the public offering.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-19
Item 5.02
Michael W. Bonney was appointed as Chair of the Board effective May 16, 2026. Mr. Bonney brings extensive executive and board leadership experience from prior CEO roles at Cubist Pharmaceuticals and Kaleido Biosciences, and this senior governance appointment is material to investors assessing the company's strategic direction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-19
Item 5.02
The disclosure centers on the appointment of Andrew Jhawar to Sprouts Farmers Market's Board of Directors as a Class III director effective May 19, 2026, with assignment to the Audit Committee. While the section also mentions Doug Rauch's retirement, the principal action disclosed is Jhawar's appointment to the board. Board composition changes are material to investors as they affect governance and oversight.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-19
Item 5.02
Vistagen appointed Angel S. Angelov, M.D., MBA as Chief Medical Officer effective May 18, 2026, with a base salary of $425,000, signing bonus, equity grants including 150,000 stock options, and bonus eligibility.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-05-19
Item 5.02
The filing discloses the election of Tim Wennes, a highly experienced financial services executive (former President and CEO of Santander Holdings USA), to serve as a Class I director effective May 28, 2026. While the section also mentions Jeff Huber's resignation, the principal disclosed action centers on the appointment of a new director with substantial industry credentials. Director appointments are material to investors assessing board composition and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-05-19
Item 5.02
Niroshan Srirathan was appointed as Interim Chief Financial Officer effective May 16, 2026, with an annual base salary of $180,000. This appointment of an interim CFO to fill the vacancy created by the prior CFO's death is material as it signals a change in financial leadership.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-19
Item 5.02
Carlos Iafigliola was appointed as President and Chief Executive Officer of Amerant Bancorp Inc. and Amerant Bank, N.A., effective May 18, 2026, following completion of an executive search.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-19
Item 5.02
EVgo Inc. appointed Amber Scott as Chief Accounting Officer and Principal Accounting Officer, effective May 18, 2026. The appointment includes compensatory arrangements comprising a base salary of $380,000, a bonus target of 55%, equity awards of $550,000, and a sign-on award of $450,000.
View raw filing on EDGAR →